Alkeran
Showing 1 - 25 of 187
Multiple Myeloma, Relapsed, Multiple Myeloma, Refractory to Standard Treatment Trial in Chicago (radiation, drug, procedure)
Completed
- Multiple Myeloma, Relapsed
- Multiple Myeloma, Refractory to Standard Treatment
- Total Marrow Irradiation
- +3 more
-
Chicago, IllinoisUniversity of Illinois Cancer Center
Nov 20, 2021
Non-Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Minneapolis (drug, procedure, biological, radiation)
Recruiting
- Non-Hodgkin Lymphoma
- Hodgkin Lymphoma
- Etoposide
- +7 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Jan 25, 2023
Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma Trial in Wuhan (Daratumumab, Carfilzomib,
Recruiting
- Multiple Myeloma
- +2 more
- Daratumumab
- +10 more
-
Wuhan, Hubei, ChinaInstitute of Hematology, Union Hospital, Tongji Medical College,
Nov 18, 2023
Multiple Myeloma Trial in Saint Petersburg (Melphalan, Nivolumab, Autologous Stem Cell Transplantation)
Recruiting
- Multiple Myeloma
- Melphalan
- +2 more
-
Saint Petersburg, Russian FederationBoris V Afanasyev, MD, Prof.
Apr 4, 2022
Multiple Myeloma Trial in Tampa (Selinexor, Melphalan, Dexamethasone)
Completed
- Multiple Myeloma
- Selinexor
- +4 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Nov 2, 2022
MDS, Graft Vs Host Disease, Graft-versus-host-disease Trial in Miami (Busulfan, Melphalan, Fludarabine)
Not yet recruiting
- Myelodysplastic Syndromes
- +2 more
- Busulfan
- +3 more
-
Miami, FloridaMiami Cancer Institute
Jan 10, 2023
Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in Miami (Total Body Irradiation (TBI), Thiotepa, Cyclophosphamide)
Not yet recruiting
- Leukemia, Myeloid, Acute
- Leukemia, Lymphocytic, Acute
- Total Body Irradiation (TBI)
- +5 more
-
Miami, FloridaBaptist Health South Florida/Miami Cancer Institute
Nov 28, 2022
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Hematopoietic Stem Cell Transplant (HSCT) Trial in Pittsburgh
Active, not recruiting
- Acute Myeloid Leukemia (AML)
- +2 more
- Reduced-Intensity Conditioning Regimen
- Myeloablative Conditioning Regimen
-
Pittsburgh, PennsylvaniaUPMC Children's Hospital of Pittsburgh
Jan 4, 2023
Sickle Cell Disease Trial in Hackensack (Alemtuzumab, Fludarabine, Melphalan)
Active, not recruiting
- Sickle Cell Disease
- Alemtuzumab
- +3 more
-
Hackensack, New JerseyHackensack University Medical Center
Feb 4, 2022
Neuroblastoma Trial in Minneapolis (drug, biological, radiation)
Recruiting
- Neuroblastoma
- Carboplatin
- +6 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Apr 11, 2022
Leukemia, Lymphoma Trial in Memphis (radiation, drug, biological, device)
Completed
- Leukemia
- Lymphoma
- Total Lymphoid Irradiation
- +10 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 28, 2022
Acute Myeloid Leukemia Trial in Miami (CPX-351, Midostaurin, Busulfan)
Recruiting
- Acute Myeloid Leukemia
- CPX-351
- +5 more
-
Miami, FloridaMiami Cancer Institute at Baptist Health of South Florida
Jul 27, 2022
Multiple Myeloma, Refractory Multiple Myeloma Trial (procedure, drug, radiation)
Withdrawn
- Multiple Myeloma
- Refractory Multiple Myeloma
- nonmyeloablative allogeneic hematopoietic stem cell transplantation
- +7 more
- (no location specified)
Jan 4, 2023
Multiple Myeloma Trial in Atlanta, Chicago (procedure, drug, other)
Recruiting
- Multiple Myeloma
- Autologous Hematopoietic Stem Cell Transplantation
- +2 more
-
Atlanta, Georgia
- +1 more
Feb 25, 2022
Leukemia Trial in Cleveland (Melphalan, Thiotepa, Fludarabine)
Recruiting
- Leukemia
- Melphalan
- +3 more
-
Cleveland, OhioUniversity Hospitals Seidman Cancer Center, Case Comprehensive C
Jan 24, 2022
Plasma Cell Myeloma Trial in Omaha (drug, procedure, biological)
Active, not recruiting
- Plasma Cell Myeloma
- Melphalan
- +4 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Nov 21, 2022
Hematopoietic Stem Cell Transplantation Trial in Cincinnati (Melphalan)
Completed
- Hematopoietic Stem Cell Transplantation
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Aug 24, 2021
Diffuse Large B Cell Lymphoma Trial in Saint Louis (Blinatumomab, Autologous stem cell transplant, Carmustine)
Active, not recruiting
- Diffuse Large B Cell Lymphoma
- Blinatumomab
- +6 more
-
Saint Louis, MissouriWashington University School of Medicine
May 4, 2022
Neuroblastoma Trial in Guangzhou (Anti Thymocyte Globulin, Fludarabine, Cyclophosphamide injection)
Not yet recruiting
- Neuroblastoma
- Anti Thymocyte Globulin
- +10 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Jun 29, 2022
Hematologic Malignancy Trial in New York (melphalan, fludarabine, thiotepa)
Active, not recruiting
- Hematologic Malignancy
- melphalan
- +7 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 21, 2022
Multiple Myeloma Trial in Torino (velcade subcutaneous melphalan prednisone, velcade cyclophosphamide prednisone, velcade
Active, not recruiting
- Multiple Myeloma
- velcade subcutaneous melphalan prednisone
- +2 more
-
Torino, ItalyA.O.U. Città della Salute e della Scienza di Torino - SC Ematolo
Mar 24, 2022
Multiple Myeloma Trial in Little Rock (myPRS, Induction 1 - MEL-10+CFZ-TD-PACE, First Transplant - MEL-80+CFZ-TD-PACE + PBSC
Terminated
- Multiple Myeloma
- myPRS
- +6 more
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
May 28, 2021
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia Trial in Tampa (Fludarabine, Melphalan, Total
Active, not recruiting
- Acute Myeloid Leukemia
- +17 more
- Fludarabine
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center & Research Institute
Jan 10, 2023